NCT03959878 Feasibility of a Constant Pressure Skin Disk (CPSD) in Enteral Tubes.
| NCT ID | NCT03959878 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Mayo Clinic |
| Condition | Gastrostomy |
| Study Type | INTERVENTIONAL |
| Enrollment | 20 participants |
| Start Date | 2019-09-30 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 20 participants in total. It began in 2019-09-30 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Researchers are gathering information on one specific part of a feeding tube, known as the adjustable skin disk. Researchers are trying to see if a new type of adjustable skin disk, called a Constant Pressure Skin Disk (CPSD), can safely and effectively support adequate healing, and reduced complication rates.
Eligibility Criteria
Inclusion Criteria: * Age greater than or equal to 22 years * Undergoing PEG tube or PEJ tube placement Exclusion Criteria: * History of tobacco or illegal drug use in the past year * History of an enteral tube * History of gastric surgery (bariatric surgery, Nissen fundoplication, etc.)
Contact & Investigator
Manpreet S Mundi, MD
PRINCIPAL INVESTIGATOR
Mayo Clinic
Frequently Asked Questions
Who can join the NCT03959878 clinical trial?
This trial is open to participants of all sexes, aged 22 Years or older, studying Gastrostomy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03959878 currently recruiting?
Yes, NCT03959878 is actively recruiting participants. Contact the research team at lorentz.paul@mayo.edu for enrollment information.
Where is the NCT03959878 trial being conducted?
This trial is being conducted at Rochester, United States.
Who is sponsoring the NCT03959878 clinical trial?
NCT03959878 is sponsored by Mayo Clinic. The principal investigator is Manpreet S Mundi, MD at Mayo Clinic. The trial plans to enroll 20 participants.